Novavax starts COVID-19 vaccine trials on children

COVID-19 deaths continue to decline in the United States
3 May 2021
3D ‘lung-on-a-chip’ model developed to test new therapies for COVID-19 and other lung conditions
3 May 2021

Novavax starts COVID-19 vaccine trials on children

US biotech firm Novavax said Monday it had started clinical trials of its proposed COVID-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.

Comments are closed.